Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Payables: 2022-2024

Historic Payables for Praxis Precision Medicines (PRAX) over the last 3 years, with Dec 2024 value amounting to $12.5 million.

  • Praxis Precision Medicines' Payables rose 105.32% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.1 million, marking a year-over-year increase of 147.47%. This contributed to the annual value of $12.5 million for FY2024, which is 115.44% up from last year.
  • As of FY2024, Praxis Precision Medicines' Payables stood at $12.5 million, which was up 115.44% from $5.8 million recorded in FY2023.
  • In the past 5 years, Praxis Precision Medicines' Payables registered a high of $14.7 million during FY2022, and its lowest value of $5.8 million during FY2023.
  • Its 3-year average for Payables is $11.0 million, with a median of $12.5 million in 2024.
  • Its Payables has fluctuated over the past 5 years, first tumbled by 60.37% in 2023, then spiked by 115.44% in 2024.
  • Praxis Precision Medicines' Payables (Yearly) stood at $14.7 million in 2022, then tumbled by 60.37% to $5.8 million in 2023, then spiked by 115.44% to $12.5 million in 2024.